Winston Sequeira
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 15 | 2019 | 174 | 2.340 |
Why?
| Polymyalgia Rheumatica | 1 | 2018 | 5 | 0.830 |
Why?
| Patient Care Management | 1 | 2018 | 15 | 0.820 |
Why?
| Symptom Assessment | 1 | 2018 | 25 | 0.810 |
Why?
| Quality of Life | 8 | 2018 | 554 | 0.730 |
Why?
| Antibodies, Antinuclear | 2 | 2017 | 21 | 0.650 |
Why?
| Immunoglobulin lambda-Chains | 1 | 2014 | 4 | 0.610 |
Why?
| Immunoglobulin kappa-Chains | 1 | 2014 | 5 | 0.610 |
Why?
| Interleukin-10 | 1 | 2014 | 41 | 0.600 |
Why?
| Interleukin-6 | 1 | 2014 | 113 | 0.580 |
Why?
| Interferon-alpha | 1 | 2014 | 82 | 0.580 |
Why?
| Patient Acuity | 2 | 2018 | 9 | 0.410 |
Why?
| Body Image | 3 | 2012 | 38 | 0.380 |
Why?
| Rheumatology | 3 | 2018 | 75 | 0.350 |
Why?
| Patient Outcome Assessment | 2 | 2018 | 48 | 0.350 |
Why?
| Health Status | 3 | 2018 | 251 | 0.320 |
Why?
| Cross-Sectional Studies | 6 | 2019 | 823 | 0.310 |
Why?
| Tuberculosis | 3 | 2009 | 24 | 0.310 |
Why?
| Self Report | 2 | 2018 | 182 | 0.310 |
Why?
| Female | 18 | 2019 | 16622 | 0.270 |
Why?
| Male | 16 | 2019 | 16222 | 0.260 |
Why?
| Reproducibility of Results | 4 | 2018 | 811 | 0.260 |
Why?
| Adult | 14 | 2019 | 9100 | 0.260 |
Why?
| Humans | 24 | 2019 | 27786 | 0.250 |
Why?
| Raynaud Disease | 1 | 2001 | 3 | 0.250 |
Why?
| Tuberculosis, Osteoarticular | 1 | 2000 | 2 | 0.240 |
Why?
| Severity of Illness Index | 6 | 2018 | 1169 | 0.230 |
Why?
| United States | 5 | 2018 | 2205 | 0.220 |
Why?
| Psychometrics | 2 | 2018 | 265 | 0.210 |
Why?
| Dimethylformamide | 1 | 1999 | 1 | 0.210 |
Why?
| Antirheumatic Agents | 3 | 2009 | 89 | 0.210 |
Why?
| Outpatient Clinics, Hospital | 1 | 2018 | 14 | 0.210 |
Why?
| Middle Aged | 12 | 2019 | 10510 | 0.210 |
Why?
| Virus Replication | 1 | 1999 | 95 | 0.200 |
Why?
| Delivery of Health Care, Integrated | 1 | 2018 | 28 | 0.200 |
Why?
| Quality Indicators, Health Care | 1 | 2018 | 41 | 0.200 |
Why?
| Pain | 2 | 2019 | 287 | 0.190 |
Why?
| Immunoglobulin G | 2 | 2009 | 135 | 0.190 |
Why?
| Arthritis, Psoriatic | 2 | 2009 | 19 | 0.190 |
Why?
| Unnecessary Procedures | 1 | 2017 | 30 | 0.180 |
Why?
| Research Design | 1 | 2018 | 203 | 0.180 |
Why?
| Pain Measurement | 1 | 2019 | 441 | 0.170 |
Why?
| Osteoarthritis, Knee | 1 | 2000 | 324 | 0.170 |
Why?
| Isoniazid | 2 | 2009 | 7 | 0.170 |
Why?
| Treatment Outcome | 4 | 2018 | 3508 | 0.170 |
Why?
| HIV-1 | 1 | 1999 | 422 | 0.160 |
Why?
| Hospitals, University | 2 | 2012 | 45 | 0.150 |
Why?
| Depression | 1 | 2019 | 471 | 0.150 |
Why?
| Longitudinal Studies | 1 | 2018 | 1298 | 0.150 |
Why?
| Health Status Indicators | 1 | 2014 | 82 | 0.150 |
Why?
| Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 14 | 0.140 |
Why?
| Dermatology | 1 | 2012 | 7 | 0.140 |
Why?
| Lupus Erythematosus, Cutaneous | 1 | 2012 | 5 | 0.140 |
Why?
| Diagnostic Self Evaluation | 1 | 2012 | 14 | 0.140 |
Why?
| Hospitals, County | 1 | 2012 | 4 | 0.140 |
Why?
| Body Dysmorphic Disorders | 1 | 2011 | 4 | 0.130 |
Why?
| Immunoglobulin Light Chains | 1 | 2011 | 9 | 0.130 |
Why?
| Rheumatic Diseases | 2 | 2009 | 56 | 0.120 |
Why?
| Aged | 4 | 2019 | 9291 | 0.120 |
Why?
| Physicians | 1 | 2012 | 100 | 0.120 |
Why?
| Quality of Health Care | 1 | 2012 | 128 | 0.120 |
Why?
| Benchmarking | 1 | 2010 | 26 | 0.120 |
Why?
| Transaminases | 1 | 2009 | 6 | 0.110 |
Why?
| Methotrexate | 1 | 2009 | 45 | 0.110 |
Why?
| Spondylitis, Ankylosing | 1 | 2009 | 43 | 0.110 |
Why?
| Vasculitis | 1 | 2009 | 35 | 0.100 |
Why?
| Activities of Daily Living | 1 | 2012 | 437 | 0.100 |
Why?
| Arthritis, Rheumatoid | 2 | 2011 | 364 | 0.100 |
Why?
| Liver | 1 | 2009 | 207 | 0.090 |
Why?
| Retrospective Studies | 5 | 2018 | 2952 | 0.090 |
Why?
| Antitubercular Agents | 2 | 2009 | 17 | 0.090 |
Why?
| Heart Auscultation | 1 | 2006 | 4 | 0.090 |
Why?
| Pulse | 1 | 2006 | 8 | 0.090 |
Why?
| Internal Medicine | 1 | 2006 | 29 | 0.080 |
Why?
| Teaching | 1 | 2006 | 62 | 0.080 |
Why?
| Internship and Residency | 1 | 2006 | 164 | 0.070 |
Why?
| Pyrazinamide | 1 | 2000 | 2 | 0.060 |
Why?
| Streptomycin | 1 | 2000 | 2 | 0.060 |
Why?
| Mycobacterium | 1 | 2000 | 3 | 0.060 |
Why?
| Ethambutol | 1 | 2000 | 4 | 0.060 |
Why?
| Rifampin | 1 | 2000 | 6 | 0.060 |
Why?
| Synovial Fluid | 1 | 2000 | 136 | 0.050 |
Why?
| HIV Core Protein p24 | 1 | 1999 | 29 | 0.050 |
Why?
| Asia | 1 | 2018 | 10 | 0.050 |
Why?
| Canada | 1 | 2018 | 49 | 0.050 |
Why?
| Appointments and Schedules | 1 | 2018 | 15 | 0.050 |
Why?
| Europe | 1 | 2018 | 75 | 0.050 |
Why?
| Morbidity | 1 | 2018 | 66 | 0.050 |
Why?
| Sex Distribution | 1 | 2018 | 89 | 0.050 |
Why?
| Tuberculin Test | 2 | 2009 | 14 | 0.050 |
Why?
| Workload | 1 | 2018 | 38 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 2 | 2009 | 40 | 0.050 |
Why?
| Cell Line | 1 | 1999 | 348 | 0.050 |
Why?
| Glucocorticoids | 1 | 2018 | 68 | 0.050 |
Why?
| Blood Sedimentation | 1 | 2017 | 64 | 0.050 |
Why?
| Health Care Surveys | 1 | 2017 | 76 | 0.050 |
Why?
| Sex Factors | 1 | 2018 | 498 | 0.050 |
Why?
| Illinois | 1 | 2017 | 235 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2007 | 228 | 0.040 |
Why?
| Chicago | 1 | 2018 | 866 | 0.040 |
Why?
| Cohort Studies | 2 | 2010 | 1773 | 0.040 |
Why?
| Matched-Pair Analysis | 1 | 2012 | 24 | 0.030 |
Why?
| Self-Assessment | 1 | 2012 | 16 | 0.030 |
Why?
| Feedback | 1 | 2012 | 24 | 0.030 |
Why?
| Self Concept | 1 | 2012 | 47 | 0.030 |
Why?
| Disease Management | 1 | 2013 | 141 | 0.030 |
Why?
| Time Factors | 1 | 2017 | 1802 | 0.030 |
Why?
| Factor Analysis, Statistical | 1 | 2011 | 71 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2013 | 451 | 0.030 |
Why?
| Sickness Impact Profile | 1 | 2011 | 21 | 0.030 |
Why?
| Reference Values | 1 | 2012 | 253 | 0.030 |
Why?
| Complementary Therapies | 1 | 2011 | 15 | 0.030 |
Why?
| Comorbidity | 1 | 2013 | 528 | 0.030 |
Why?
| Adaptation, Psychological | 1 | 2011 | 163 | 0.030 |
Why?
| Case-Control Studies | 1 | 2012 | 643 | 0.030 |
Why?
| Prognosis | 1 | 2013 | 969 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2011 | 324 | 0.030 |
Why?
| Arthritis, Juvenile | 1 | 2009 | 8 | 0.030 |
Why?
| Mycobacterium tuberculosis | 1 | 2009 | 17 | 0.030 |
Why?
| Age Factors | 1 | 2012 | 869 | 0.030 |
Why?
| Aged, 80 and over | 1 | 2019 | 4766 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2013 | 1163 | 0.020 |
Why?
| Prospective Studies | 1 | 2011 | 1668 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2006 | 33 | 0.020 |
Why?
| Risk Assessment | 1 | 2009 | 747 | 0.020 |
Why?
| Adolescent | 1 | 2012 | 2439 | 0.020 |
Why?
| Educational Measurement | 1 | 2006 | 63 | 0.020 |
Why?
| Young Adult | 1 | 2012 | 2047 | 0.020 |
Why?
| Physical Examination | 1 | 2006 | 109 | 0.020 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 103 | 0.020 |
Why?
| Immunosuppressive Agents | 1 | 2006 | 159 | 0.020 |
Why?
| Cardiology | 1 | 2006 | 90 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2006 | 372 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2007 | 1933 | 0.020 |
Why?
| Risk Factors | 1 | 2007 | 2387 | 0.010 |
Why?
|
|
Sequeira's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|